Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2 Clinical Study Evaluating MDX2003 in Participants With Relapsed, Progressive, or Refractory B-Cell Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07249905
Title field or adapter rule
{'original_value': 'A Phase 1/2 Clinical Study Evaluating MDX2003 in Participants With Relapsed, Progressive, or Refractory B-Cell Malignancies', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-11-01T01:03:15.761284+00:00
Published At
2026-10-28T00:00:00+00:00
Record Updated At
2026-10-28
Source Retrieved At
2026-11-01T01:03:15.424322+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lymphoma", "Waldenstr\u00f6m Macroglobulinemia (WM)", "DLBCL - Diffuse Large B Cell Lymphoma", "PMBCL", "HGBCL", "FL Lymphoma", "Lymphoplasmacytic Lymphoma", "Follicular Lymphoma (FL)"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07249905"
protocolSection.identificationModule.officialTitle
"A Phase 1/2 Clinical Study Evaluating MDX2003 in Participants With Relapsed, Progressive, or Refractory B-Cell Malignancies"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Waldenström Macroglobulinemia (WM) (protocolSection.conditionsModule.conditions)
  • DLBCL - Diffuse Large B Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • PMBCL (protocolSection.conditionsModule.conditions)
  • HGBCL (protocolSection.conditionsModule.conditions)
  • FL Lymphoma (protocolSection.conditionsModule.conditions)
  • Lymphoplasmacytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Follicular Lymphoma (FL) (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Dose Escalation- Part A', 'Indication Optimization- Part B'], 'description': 'MDX2003 intravenous infusion', 'name': 'MDX2003', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • MDX2003 (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.